Relationship between antibody to cytotoxin end Helicobacter pylori infection

Journal of Physiology and Pharmacology

Volumn 48, Issue 3, 1997, Pages 415-421

  Gosciniak G ^a   Przondo Mordarska, A ^a   Poniewierka, E ^a   Iwanczak B ^a   Bilska, A ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antibody to cytotoxin; H. pylori; Vacuolating cytotoxin

Indexed keywords

CYTOTOXIN; NEUTRALIZING ANTIBODY; TISSUE CULTURE MEDIUM;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CELL CULTURE; CELL VACUOLE; CHRONIC GASTRITIS; CONTROLLED STUDY; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; SCHOOL CHILD;

ADULT; ANTIBODY FORMATION; BACTERIAL TOXINS; CHILD; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NEUTRALIZATION TESTS;

EID: 1842410719     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Goldstone AR, Quirke P, Dixon MF. Helicobacter pylori infection and gastric cancer. J Pathol 1966; 179: 129-137.
2. Leunk RD, Johnston PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26; 93-99.
3. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in H. pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603-610.
4. Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by H. pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-5012.
5. Morgan AP. Pathogenic properties of H. pylori. Scand J Gastroenterol 1996; 31 suppl 215: 22-31.
6. Noach LA, Rolf TM, Tytgat GNJ. Electron microscopic study of association between H. pylori and gastric and duodenal mucosa. J Clin Pathol 1994; 47: 699-704.
7. Atherton JC, Cao P, Peek RM Jr, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of H. pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777.
8. Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogenity in vacA, the vacuolating cytotoxin gene of H. pylori. Gastroenterology 1997; 112: 92-99.
9. Gaszewska-Mastalarz A, Zakrzewska-Czerwinska J, Gosciniak G, Przondo-Mordarska A. Nucleotide sequences divergence of the vacuolating cytotoxin gene among H. pylori strains. IUMS Congresses. 8th International Congress of Bacteriology and Applied Microbiology Division. Jerusalem, Israel, 1996; Abstracts: 76.
10. Xiang Z, Censini S, Bayeli PF et al. Analysis of H. pylori reveals that the clinical isolates can be divided into two major types and that cagA is not necessary for expression of the vacuolating toxin. Infect Immun 1995; 63: 94-98.
11. Figura N. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment Pharmacol Ther 1996; suppl 1: 79-96.
12. Weel JF, van-der-Hulst RW, Gerrists Y et al. The interrelationship between cytotoxin-associated geneA, vacuolating cytotoxin, and H. pylori-related diseases. J Infect Dis 1996; 173: 1171-1175.
13. Cover TL, Cao P, Murthy UK, Sipple MS, Blaser MJ. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 1992; 90: 913-918.
14. + H. pylori strains. J Clin Microb 1995; 33: 1496-1500.
15. Gosciniak G, Klakocar J, Przondo-Mordarska A, Mauff G. Helicobacter pylori antibodies in sera of children suffering from chronic abdominal pain. Zbl Bakt 1993; 280: 214-220.
16. Goossens H, Glupczynski Y, Burette A, Lambert JP, Vlaes L, Butzler JP. Role of the vacuolating toxin from H. pylori on the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1992; 1: 153-159.
17. Figura N, Tabaqchali S. Bacterial pathogenic factors. Current Opinion Gastroenterol 1996; 12 (suppl 1): 11-15.
18. Mégraud F. Toxic factors of H. pylori. Eur J Gastroenterol Hepatol 1994; 6 suppl 1: S5-S10.
19. Figura N, Guglielmetti P, Rossolini A, Barberi A. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chrionic gastritis only. J Clin Microbiol 1989; 27: 225-226.
20. Tee W, Lambert JR, Dwyer B. Cytotoxin production by H. pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995; 33: 1203-1205.
21. Glupczynski Y. Contribution to the diagnosis, epidemiology, pathogenesis and treatment of H. pylori. Universite libre de Bruxelles faculte de medicine 1993: 1-298.
22. Leunk RD, Ferguson MA, Morgan DR, Low DE, Simor AE. Antibody to cytotoxin in infection by H. pylori. J Clin Microbiol 1990; 28: 1181-1184.